Researcher

Xiao Zhang

Affiliated Hospital of Jining Medical University

3 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

AUG 12, 2026 · JOURNAL ARTICLE

Radioactive copper (64Cu)-enabled theranostic delivery modulates cuproptosis-associated signaling for cancer treatment

Journal of Nanobiotechnology

This is a preclinical mechanistic study in murine glioblastoma models demonstrating a novel theranostic approach; it lacks human data, control comparators, and independent replication needed for clinical translation.

PreliminaryYuan Feng Ruochen Tan Xiaoyan Li

Reported

Tumor accumulation (%ID/g)7.66 ± 0.93

Median survival (days)36

AUG 11, 2026 · JOURNAL ARTICLE

Case Report: Immune checkpoint inhibitor-induced myositis/myocarditis with myasthenia gravis-like symptoms in a colon cancer patient with suspected thymic metastasis

Frontiers in Oncology

A single uncontrolled case report describing an unusual adverse event triad; raises awareness but provides no comparative data or generalizable evidence on incidence, risk factors, or optimal management.

PreliminaryPeng Li Guijuan Wang Hui-Li Wang

Reported

Number of ICI cycles before sympt…1

AUG 11, 2026 · JOURNAL ARTICLE

A report on the mechanisms of sweeteners in four musculoskeletal disorders: Insights from network toxicology, molecular docking, and molecular dynamics simulations

PLOS One

Computational modelling study with no experimental validation, clinical data, or human evidence; raises mechanistic questions about sweetener effects on musculoskeletal health but does not answer them.

Hypothesis-GeneratingPharmacology and Obesity Treatment Cao Donghui Tengyao Niu

Reported

Number of predicted core targets35